Sponsors move along their own track scientific innovation, development strategy, evidence generation while regulators, payers, and HTA bodies sit on a parallel track governed by review standards, reimbursement criteria, and adoption decisions. The gap opens wherever the first track gets ahead of, or simply diverges from, the second. Closing it isn't something you do once, near the end. It takes ongoing, iterative contact between the two tracks for the life of the program.